Acknowledgements Illustrations were created with Biorender
Enhancing physical performance
Secondary, safety and negative control endpoints For individual components of the primary endpoint, semaglutide versus sitagliptin reduced myocardial infarction (HR 0.81, 95% CI 0.70 to 0.92) and stroke (HR 0.84, 95% CI 0.71 to 0.99) in the expanded populations at low, moderate and high cardiovascular risk
Carrying fast-acting glucose during workouts is standard practice
Gold plans typically have low deductibles and cheap copays and coinsurance
Why It Matters Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study author Edy Kornelius, MD, PhD, of Chung Shan Medical University in Taichung, Taiwan